Skip to main content
TRUP logo

TRUP · Trupanion, Inc.

Track TRUP — free
Market Cap
$1.09B
Shares
43.87M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$24.89 Open$25.00 Day$24.52–25.38 52W close$21.46–45.19 Avg vol 30d555K Short int4.0M · 9.1% float · 8.9d Short vol45% Last earningsAug 5, 2026 DataJan 2020–Sep 2026 Filing10-Q · Aug 5

Up next

Next earnings call
Nov 7, 2026 Est · unconfirmed · in 8 wks
filed Aug 5, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.52B
Trailing 12 months
Net income (TTM)
−$21.18M
Trailing 12 months
Revenue growth YoY
+11.1%
Year over year
Operating margin
1.6%
Trailing 12 months
P / E (TTM)
47.0
Trailing earnings · reciprocal yield 2.1%
FCF yield
7.5%
TTM · current market cap
Return on invested capital
18.1%
Trailing 12 months
Net cash
$291.58M
Latest balance sheet
Dividend yield
Trailing 12 months
Shares change YoY
+1.1%
Year over year · more shares
Price change (1Y)
-42.7%
Trailing year
Short interest
9.1%
Latest settlement · 8.9 days to cover
View all 115 metrics

AI Brief

Q2 FY26 earnings call · Aug 5, 2026
Q2 FY26

TL;DR. Trupanion delivered 24% subscription adjusted operating income growth and raised/narrowed full-year AOI guidance to $176–184M while announcing a $100M share repurchase program backed by a $44M insurance entity dividend. Net pet adds accelerated 39% on improved enrollment conversion and higher LTV.

Bullish
  • + Subscription adjusted operating income grew 24% YoY to $41.4M with margin expanding to 15%
  • + Net subscription pet adds accelerated 39% YoY with gross pet ads up 9% and LTV up 25%
  • + Full-year 2026 adjusted operating income guidance raised to a range of $176M–$184M (~19% growth at midpoint)
  • + Board authorized $100M share repurchase program following $44M insurance entity dividend approval
  • + Free cash flow grew to $19.2M in Q2 and operating cash flow reached $21M
Bearish
  • Net income declined to $6.8M ($0.16/share) from $9.4M ($0.22/share), partly as prior year included a $7.8M one-time gain
  • Total enrolled pets declined 2% YoY to 1,633,131 due to other business segment contraction
  • Pet acquisition cost per pet rose to $299 from $276 YoY
  • Veterinary inflation remains elevated at double-digit levels, pressuring pricing and claims costs

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Bearish Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 15.8 · calm Equity put/call 0.58
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −12%
below
Price vs 50-day avg −9%
below
RSI (14) 35
neutral
MACD trend Negative
52-week position 14%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −20%
trailing
6-month return −5%
trailing
YTD return −33%
this year
Relative strength −23%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $27 › 200d $28 — 200d above 50d
Institutional flow Distributing
-1% holders QoQ · +33 funds added
Insider flow Distributing
Net -$199.0K over 90 days · 100% sells
Short interest Rising
9.10% of float · ▲ +0.6% MoM · 8.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
201 holders — near 3-yr low, contrarian setup
Squeeze score 65
elevated · 0–100
Fundamentals
Excellent
Revenue growth +12%
Y/Y
Gross margin 5%
expanding
EPS growth +296%
Y/Y
Free cash flow $75.4M
Valuation P/E 47
rich
Buyback $100.0M
authorized
Balance sheet $26.2M
net cash
Quant / Vol
risk profile
Very High
Volatility 46%
annualized · 1-yr
Max drawdown −53%
past year
ATR 5.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 2 of last 2
Latest guidance · from the Earnings Call filed Jun 30, 2026
full year of 2026
Total revenue Initiated $1.58B – $1.6B
prior FY $1.44B midpoint +10.6% Y/Y
Total adjusted operating income Non-GAAP Initiated $176M – $184M
third quarter of 2026
Total revenue Initiated $399M – $405M
prior qtr $392.93M midpoint +2.3% QoQ
Prior guidance period ended · from the Earnings Call filed Nov 3, 2021
Adjusted operating income · full year 2021 $77M
Guided vs delivered · last 2 settled
Total revenue full-year 2021
guided $674M – $682M
$698.99M Beat +3.1%
Total revenue second quarter 2021
guided $164M – $166M
$168.26M Beat +2.0%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−12% Bearish
Price vs 50-day avg
−9% Bearish
RSI (14)
35 Neutral
MACD trend
Negative Bearish
52-week position
14% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross) No cross
50d $27 › 200d $28 — 200d above 50d
Institutional flow Distributing
-1% holders QoQ · +33 funds added
Insider flow Distributing
Net -$199.0K over 90 days · 100% sells
Short interest Rising
9.10% of float · ▲ +0.6% MoM · 8.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
201 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $21 Now $25 · 14% Range high $45
vs 200-day avg -12% vs 50-day avg -9%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Insurance - Property & Casualty — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
TRUP
Trupanion, Inc.
this stock
$1.09B -33.4% +11.9% 47.0 9.1%
CB
Chubb Ltd
$131.19B +8.4% +6.5% 12.0 0.8%
PGR
Progressive Corp/Oh/
$126.52B -4.4% +16.3% 10.9 1.0%
TKOMY
Tokio Marine Holdings, Inc.
$99.34B +41.4% 0.0%
TRV
Travelers Companies, Inc.
$78.26B +29.4% +5.2% 10.1 2.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
201
% held
77.3%
Net QoQ
+415.9K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
227
View
Short & Settlement
Short Interest Rising
Shares short
4.0M
Days to cover
8.9d
Change
+23.2K sh
View
Short Volume
Short vol %
45%
As of
Sep 11, 2026
Short Total
View
Fails to Deliver
FTD shares
10
Value
$305
As of
Aug 12, 2026
View
Off-Exchange
Off-exchange %
39.3%
Week of
Aug 3, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$199.0K
Buyers / Sellers
0 / 2
Buyers Sellers
View
Congressional Trades Sell
Member
Bradley S. Schneider
Amount
$50.0K–$100.0K
Traded
Dec 10, 2021
View
Financials
Financials
Revenue (FY)
$1.4B
Net income (FY)
$19.4M
EPS diluted
$0.45
View
Buybacks
Authorized
$100.0M
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 5, 2026
This year
9
View
Proposed Sales
Value
$25.0K
Shares
1.0K
Filed
Sep 11, 2026
View
Exempt Offerings
Offering
$200.0M
Filed
Nov 2, 2020
View
Earnings & Events
Earnings Calls
Last call
Aug 5, 2026
View
Investor Relations
Latest news
Trupanion Searches for this Year’…
Published
Sep 10, 2026
View

Performance

5D 20D 120D MTD YTD
TRUP -13.6% -19.7% -5.0% -14.6% -33.4%
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY -12.4% -18.0% -22.9% -14.3% -45.5%

Capital returns

Buyback program · as of Aug 5, 2026
Authorized
$100.00M
Spent (derived)
Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1371285 CUSIP 898202106 13F (30d) 64 filings 64 filers Visit website Investor relations